skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 620  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV
Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV
Material Type:
Article 		Add to My Research

Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV

British journal of ophthalmology, 2017-03, Vol.101 (3), p.353-359 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/2017This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:http://creativecommons.org/licenses/by-nc/4.0 ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2017 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2016-308668 ;PMID: 27215744

Full text available

Citations Cited by
2
Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion: 1-Year Results From the Phase 3 COPERNICUS Study
Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion: 1-Year Results From the Phase 3 COPERNICUS Study
Material Type:
Article 		Add to My Research

Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion: 1-Year Results From the Phase 3 COPERNICUS Study

American journal of ophthalmology, 2013-03, Vol.155 (3), p.429-437.e7 [Peer Reviewed Journal]

Elsevier Inc. ;2013 Elsevier Inc. ;Copyright © 2013 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2012.09.026 ;PMID: 23218699 ;CODEN: AJOPAA

Full text available

Citations Cited by
3
Macular Edema in Central Retinal Vein Occlusion Correlates With Aqueous Fibrinogen Alpha Chain
Macular Edema in Central Retinal Vein Occlusion Correlates With Aqueous Fibrinogen Alpha Chain
Material Type:
Article 		Add to My Research

Macular Edema in Central Retinal Vein Occlusion Correlates With Aqueous Fibrinogen Alpha Chain

Investigative ophthalmology & visual science, 2023-02, Vol.64 (2), p.23-23 [Peer Reviewed Journal]

Copyright 2023 The Authors 2023 ;ISSN: 1552-5783 ;ISSN: 0146-0404 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.64.2.23 ;PMID: 36820679

Full text available

Citations Cited by
4
Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes
Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes
Material Type:
Article 		Add to My Research

Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes

British journal of ophthalmology, 2021-12, Vol.105 (12), p.1696-1704 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2020-317337 ;PMID: 33055088

Full text available

Citations Cited by
5
Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein Occlusion
Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein Occlusion
Material Type:
Article 		Add to My Research

Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein Occlusion

American journal of ophthalmology, 2024-04, Vol.260, p.147-159 [Peer Reviewed Journal]

2023 The Authors ;Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2023.11.023 ;PMID: 38061584

Full text available

Citations Cited by
6
New individualized aflibercept treatment protocol for branch retinal vein occlusion with macular edema
New individualized aflibercept treatment protocol for branch retinal vein occlusion with macular edema
Material Type:
Article 		Add to My Research

New individualized aflibercept treatment protocol for branch retinal vein occlusion with macular edema

Scientific reports, 2023-01, Vol.13 (1), p.1536-1536, Article 1536 [Peer Reviewed Journal]

2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-023-28533-z ;PMID: 36707696

Full text available

Citations Cited by
7
Response to Comment on Lee et al. Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score-Matched Cohort Study. Diabetes Care 2021; 44:2419-2426
Response to Comment on Lee et al. Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score-Matched Cohort Study. Diabetes Care 2021; 44:2419-2426
Material Type:
Article 		Add to My Research

Response to Comment on Lee et al. Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score-Matched Cohort Study. Diabetes Care 2021; 44:2419-2426

Diabetes care, 2022-02, Vol.45 (2), p.e38-e38 [Peer Reviewed Journal]

ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dci21-0049 ;PMID: 35050367

Full text available

Citations Cited by
8
Retinal vein occlusion in COVID-19: A novel entity
Retinal vein occlusion in COVID-19: A novel entity
Material Type:
Article 		Add to My Research

Retinal vein occlusion in COVID-19: A novel entity

Indian journal of ophthalmology, 2020-10, Vol.68 (10), p.2291-2293 [Peer Reviewed Journal]

COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd. ;2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright: © 2020 Indian Journal of Ophthalmology 2020 ;ISSN: 0301-4738 ;EISSN: 1998-3689 ;DOI: 10.4103/ijo.IJO_2380_20 ;PMID: 32971697

Full text available

Citations Cited by
9
Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion
Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion
Material Type:
Article 		Add to My Research

Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion

American journal of ophthalmology, 2017-10, Vol.182, p.160-167 [Peer Reviewed Journal]

2017 Elsevier Inc. ;Copyright © 2017 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Oct 1, 2017 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2017.08.005 ;PMID: 28837790

Full text available

Citations Cited by
10
OCT Grading System of Macular Infarction Predicts Vision in Participants With Central Retinal or Hemiretinal Vein Occlusion: A Secondary Analysis of SCORE2
OCT Grading System of Macular Infarction Predicts Vision in Participants With Central Retinal or Hemiretinal Vein Occlusion: A Secondary Analysis of SCORE2
Material Type:
Article 		Add to My Research

OCT Grading System of Macular Infarction Predicts Vision in Participants With Central Retinal or Hemiretinal Vein Occlusion: A Secondary Analysis of SCORE2

American journal of ophthalmology, 2023-12, Vol.256, p.55-62 [Peer Reviewed Journal]

2023 ;Published by Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2023.07.028 ;PMID: 37544495

Full text available

Citations Cited by
11
Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans
Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans
Material Type:
Article 		Add to My Research

Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans

American journal of ophthalmology, 2012-10, Vol.154 (4), p.682-686.e2 [Peer Reviewed Journal]

Elsevier Inc. ;2012 Elsevier Inc. ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2012.03.047 ;PMID: 22818800 ;CODEN: AJOPAA

Full text available

Citations Cited by
12
VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study
VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study
Material Type:
Article 		Add to My Research

VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study

British journal of ophthalmology, 2013-03, Vol.97 (3), p.278-284 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Copyright: 2013 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2012-301504 ;PMID: 23298885 ;CODEN: BJOPAL

Full text available

Citations Cited by
13
Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therapy
Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therapy
Material Type:
Article 		Add to My Research

Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therapy

British journal of ophthalmology, 2022-01, Vol.106 (1), p.113-120 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2020-317416 ;PMID: 33087314

Full text available

Citations Cited by
14
Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion
Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion
Material Type:
Article 		Add to My Research

Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion

Archives of ophthalmology (1960), 2019-01, Vol.137 (1), p.38 [Peer Reviewed Journal]

Copyright American Medical Association Jan 2019 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2018.4484

Full text available

Citations Cited by
15
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
Material Type:
Article 		Add to My Research

Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry

British journal of ophthalmology, 2023-06, Vol.107 (6), p.842-848 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2021-320482 ;PMID: 35078771

Full text available

Citations Cited by
16
Exacerbation of branch retinal vein occlusion post SARS-CoV2 vaccination: Case reports
Exacerbation of branch retinal vein occlusion post SARS-CoV2 vaccination: Case reports
Material Type:
Article 		Add to My Research

Exacerbation of branch retinal vein occlusion post SARS-CoV2 vaccination: Case reports

Medicine (Baltimore), 2021-12, Vol.100 (50), p.e28236 [Peer Reviewed Journal]

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000028236 ;PMID: 34918688

Full text available

Citations Cited by
17
Benefits of a Laser Chorioretinal Anastomosis Plus Ranibizumab vs Ranibizumab Alone for Central Retinal Vein Occlusion: 4-Year Results
Benefits of a Laser Chorioretinal Anastomosis Plus Ranibizumab vs Ranibizumab Alone for Central Retinal Vein Occlusion: 4-Year Results
Material Type:
Article 		Add to My Research

Benefits of a Laser Chorioretinal Anastomosis Plus Ranibizumab vs Ranibizumab Alone for Central Retinal Vein Occlusion: 4-Year Results

American journal of ophthalmology, 2023-08, Vol.252, p.101-110 [Peer Reviewed Journal]

2023 Elsevier Inc. ;Copyright © 2023 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2023.03.034 ;PMID: 37030494

Full text available

Citations Cited by
18
Investigation into safflower injection as a prophylactic treatment for retinal vein occlusion in a rabbit model
Investigation into safflower injection as a prophylactic treatment for retinal vein occlusion in a rabbit model
Material Type:
Article 		Add to My Research

Investigation into safflower injection as a prophylactic treatment for retinal vein occlusion in a rabbit model

Scientific reports, 2024-04, Vol.14 (1), p.8048-8048 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-024-58734-z ;PMID: 38580804

Full text available

Citations Cited by
19
Retinal vein occlusions before and during the COVID-19 pandemic. Visual outcomes and treatment patterns in a country with no mandatory lockdown
Retinal vein occlusions before and during the COVID-19 pandemic. Visual outcomes and treatment patterns in a country with no mandatory lockdown
Material Type:
Article 		Add to My Research

Retinal vein occlusions before and during the COVID-19 pandemic. Visual outcomes and treatment patterns in a country with no mandatory lockdown

Retina (Philadelphia, Pa.), 2024-06 [Peer Reviewed Journal]

ISSN: 1539-2864 ;EISSN: 1539-2864 ;DOI: 10.1097/IAE.0000000000004065

Digital Resources/Online E-Resources

Citations Cited by
20
Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry
Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry
Material Type:
Article 		Add to My Research

Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry

Scientific reports, 2024-03, Vol.14 (1), p.6122-6122 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-024-56581-6 ;PMID: 38480837

Full text available

Citations Cited by

Results 1 - 20 of 620  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (576)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1999  (12)
  2. 1999 To 2004  (37)
  3. 2005 To 2010  (112)
  4. 2011 To 2017  (256)
  5. After 2017  (204)
  6. More options open sub menu

Resource Type 

  1. Articles  (619)
  2. Book Chapters  (1)
  3. More options open sub menu

Language 

  1. English  (594)
  2. Japanese  (74)
  3. German  (11)
  4. Spanish  (9)
  5. French  (8)
  6. Portuguese  (6)
  7. Chinese  (1)
  8. Korean  (1)
  9. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait